微芯生物(688321.SH):部分股東不再構成一致行動關係
格隆匯1月17日丨微芯生物(688321.SH)公佈,收到股東方深圳市海德睿達企業管理合夥企業(有限合夥)、南昌海德睿遠企業管理合夥企業(有限合夥)(分別簡稱“海德睿達”、“海德睿遠”)和XIANPINGLU博士出具的《關於不再構成一致行動關係的吿知函》。因海德睿達、海德睿遠與XIANPINGLU博士簽署的《一致行動協議》中約定的在公司上市後36個月內保持一致行動關係的期限已屆滿,海德睿達、海德睿遠各自的全體合夥人一致同意將XIANPINGLU博士由海德睿達、海德睿遠的普通合夥人兼執行事務合夥人變更為有限合夥人。經海德睿達、海德睿遠各自執行事務合夥人同意,海德睿達、海德睿遠與XIANPINGLU博士簽署了《一致行動協議之補充協議》,解除其與XIANPINGLU博士之間的一致行動關係。本次權益變動不涉及公司股東持股數量變動,不涉及公司控股股東及實際控制人變更。
海德睿達、海德睿遠自願承諾:與XIANPINGLU博士解除一致行動關係之日起6個月內(即2025年1月17日至2025年7月16日,簡稱“鎖定期”),不以任何形式減持其所持有的微芯生物股份,也不由微芯生物回購其所持有的微芯生物的股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.